Evidence map›Paper›PMID 42430434›Full record

ArticlePloS one2026

ProbStab: A probabilistic ML-assisted pipeline for genotype performance, stability, and risk evaluation in multi-environment trials.

Mohammadreza Shiri

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mohammadreza ShiriDepartment of Maize and Forage Crops Research, Seed and Plant Improvement Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.ORCID https://orcid.org/0000-0002-1993-5581

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In multi-environment trials (MET), ignoring genotype × environment interaction (GEI) can lead to suboptimal cultivar recommendations and increased risk in breeding decisions. To make informed decisions, it is important to select genotypes that combine high yield with a low chance of very poor performance. Recent advances in artificial intelligence and machine learning (ML) enable researchers to study complex patterns in MET data, improving the screening and selection of superior genotypes. In this study, we introduce the statistical package ProbStab, which was developed to evaluate the yield, stability, and risk of genotypes in MET. ProbStab is based on Quantile Regression Forests, a non-parametric algorithm that provides reliable prediction intervals and addresses the limitations of classical methods. The package includes several probabilistic modules (ml_tcp_pipe, prob_stab_pipe, ci_perf_pipe, risk_potential_pipe). Using bootstrapping and machine learning, these modules estimate key indicators, including the probability of superior yield, the probability of superior stability, the joint probability of yield and stability, and measures of risk and performance potential. This integrated design fills a crucial gap in conventional approaches, providing a practical tool for advanced probabilistic analysis. By combining MLwith probabilistic evaluation, ProbStab gives plant breeders and agronomists a novel framework to reduce uncertainty in decision-making. The main goal of ProbStab is to support breeding programs with a clear, data-driven, and efficient approach for selecting stable and high-yielding genotypes under complex GEI conditions and to improve the reliability of cultivar recommendations for farmers.

Indexed as

Gene-Environment InteractionGenotypeMachine LearningPlant BreedingAlgorithmsPrediction AlgorithmsRisk Assessment

Identifiers

PMID42430434
PMCPMC13354077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.